全部

1·The expression of thymidylate synthase may be one of the important prognostic indicator for endometrial carcinoma.

熊苷酸合成酶的表达可能是子宫内膜癌患者一项重要的预后指标。

2·This protein has been purified from Sclerotinia sclerotiorum and the EPSP synthase has been analyzed.

该蛋白是从菌核病菌核菌中纯化得到的。

3·Nitric oxide synthase activity may also result in the subsequent activation of guanylyl cyclase and PKG.

一氧化氮合酶活性也可能导致随后的冠状液环化酶和 PKG 的激活。

4·Erythroid-specific 5-aminolevulinate synthase (ALAS2) catalyzes the rate-limiting step in heme biosynthesis.

红系特异的5-氨基酮戊酸合成酶（ALAS2）是血红素生物合成的限速酶。

5·Nitric Oxide Synthase, Rat Brain, Recombinant.

一氧化氮合酶， 大鼠脑， 重组。

6·In ATP-synthase F0 drives F1 in reverse, causing it to generate ATP.

在AT P合成酶中，F0反向驱动f1，促其产生腺苷三磷酸。

7·Chitin synthase is the important enzyme that converts UDP - GlcNAc to chitin.

摘要几丁质合成酶是生物合成几丁质的关键物质。

8·Glycogen synthase (GS) is a key enzyme in the regulation of glycogen synthesis.

糖元合成酶(GS)是糖元合成调节中的关键酶。

9·The citrate synthase of mammalian tissues have been shown to be inhibited by ATP.

有人已经证实哺乳动物组织的柠檬酸合成酶受atp的抑制。

10·Objective: To locate nitric oxide synthase (NOS) in the chicken vestibular system.

目的：观察一氧化氮合酶(NOS)在雏鸡外周前庭系统中的分布。

合酶

1·Nitric oxide synthase activity may also result in the subsequent activation of guanylyl cyclase and PKG.

一氧化氮合酶活性也可能导致随后的冠状液环化酶和 PKG 的激活。

2·The up regulation of inducible nitric oxide synthase ( iN OS ) often negatively modulates myocardial function.

诱导型一氧化氮合酶的诱导表达往往导致心肌的收缩功能下降。

3·However, the involvement of tyrosine kinase either directly or through the prostaglandins and nitric oxide synthase in response to inflammation during diabetes is not completely understood.

不过，酪氨酸激酶是直接参与还是通过前列腺素和一氧化氮合酶对糖尿病炎症产生反应的，我们目前还不知道。

4·Using the above improved genetic transformation system, we have got some transformed plants of anti-sense squalene synthase gene.

利用上述改进的青蒿遗传转化体系，我们得到了反义鲨烯合酶基因的青蒿转化植株。

5·Fatty acid synthase (FAS) is reported as a potential new therapeutic target for obesity. However, there are limited known FAS inhibitors presently.

最新报道脂肪酸合酶(FAS)是治疗肥胖症的潜在靶部位，但目前已知的FAS抑制剂还很少。